InvestorsHub Logo
Followers 11
Posts 1516
Boards Moderated 0
Alias Born 10/20/2014

Re: b9molecule post# 18619

Wednesday, 11/19/2014 4:37:29 PM

Wednesday, November 19, 2014 4:37:29 PM

Post# of 47873
B9- well to say the unit price is NOT important news to investors is a mis in my view. I am NOT saying that is what you are saying. But here's why its important: investors are doing the calculations on margin gained from units sold vs. amount of debt against the growing dilution.

These issues may be irrelevant to the ceo as he may already have a debt resolution event in the pipeline. So any talk of paying off debt or what a unit sells for under the $162M IDIQ is not the first thing he worries about. Further, I don't sense he wants a known price/unit floating around the markets. You can well imagine the damage that could potentially do.

My other thought, why would IMSC ever bid itself down by fire-sale pricing the most advanced etd available- they would not. Matter of fact, the tendancy would be to over price it in the vacuum of real competition. ( note Smiths and Morpho etds are still certified but undesired=not real competition).

The aspect of the last conf. call that sort of threw me for a loop-- prior calls all referred to IMSC's B-220 as the new specification, meaning, tested against the latest threat substances and on the latest surfaces...so Smiths and Morphos etd units are defunctional by specification but still in service. To my mind, that points to a faster replacement cycle than what we have heard but another issue that IMSC cannot talk about as production capacity is evolving/growing.

I agree that the 21M$ order is for a partial # of this year's quantity of 1130 B-220s. So I think he delivers the full quantity (1130) before Sept.'15 but doesn't want that in guidance or the record before it is a certainty.

Best of Better Luck to ALL IMSC LONGS!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.